BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10640628)

  • 1. Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g).
    Sogawa CA; Miyazaki I; Sogawa N; Asanuma M; Ogawa N; Furuta H
    Brain Res; 2000 Jan; 853(2):310-6. PubMed ID: 10640628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory effects of 4-methylcatechol, dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VR-2g).
    Aoki C; Nakanishi T; Sogawa N; Ishii K; Ogawa N; Takigawa M; Furuta H
    Brain Res; 1998 May; 792(2):335-9. PubMed ID: 9593981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex.
    Stenkamp K; Heinemann U; Schmitz D
    Neurosci Lett; 1998 Oct; 255(2):119-21. PubMed ID: 9835229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and beta2 receptors.
    Ding G; Wiegerinck RF; Shen M; Cojoc A; Zeidenweber CM; Wagner MB
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2327-35. PubMed ID: 18375720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway.
    Hara H; Ohta M; Adachi T
    J Neurosci Res; 2006 Sep; 84(4):860-6. PubMed ID: 16802348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
    Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
    PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
    Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M
    Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
    Miyazaki I; Asanuma M; Hozumi H; Miyoshi K; Sogawa N
    FEBS Lett; 2007 Oct; 581(25):5003-8. PubMed ID: 17910954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin and dopamine stimulate ghrelin secretion by the ghrelin-producing cell line, MGN3-1 in vitro.
    Iwakura H; Ariyasu H; Hosoda H; Yamada G; Hosoda K; Nakao K; Kangawa K; Akamizu T
    Endocrinology; 2011 Jul; 152(7):2619-25. PubMed ID: 21521750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors influence vasoactive intestinal peptide release from turkey hypothalamic explants.
    Chaiseha Y; Youngren OM; el Halawani ME
    Neuroendocrinology; 1997 Jun; 65(6):423-9. PubMed ID: 9208404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
    Lindgren HS; Ohlin KE; Cenci MA
    Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.
    Auteri M; Zizzo MG; Amato A; Serio R
    J Physiol Biochem; 2016 Aug; 73(3):395-404. PubMed ID: 28600746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of metallothionein genes in mouse brain.
    Choudhuri S; Kramer KK; Berman NE; Dalton TP; Andrews GK; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):144-54. PubMed ID: 7878670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.
    Ishige K; Chen Q; Sagara Y; Schubert D
    J Neurosci; 2001 Aug; 21(16):6069-76. PubMed ID: 11487630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of metallothionein isoforms in human chorioretinal complex.
    Tate DJ; Miceli MV; Newsome DA
    Curr Eye Res; 2002 Jan; 24(1):12-25. PubMed ID: 12187490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.